Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Meet Clicklinks: The Innovation Hub for Original Drug Discovery
      Biotech

      Meet Clicklinks: The Innovation Hub for Original Drug Discovery

      May 24, 2026
      Protein Expression Market worth $7.65 billion by 2031 | MarketsandMarkets™
      Biotech

      Protein Expression Market worth $7.65 billion by 2031 | MarketsandMarkets™

      May 23, 2026
      Formosa Pharmaceuticals Announces Presentation of TSY-310 at the 2026 ASCO Annual Meeting
      Biotech

      Formosa Pharmaceuticals Announces Presentation of TSY-310 at the 2026 ASCO Annual Meeting

      May 22, 2026
      BioMarin Announces Positive Phase 3 Pivotal Study Results for VOXZOGO® (vosoritide) in Children with Hypochondroplasia
      Biotech

      BioMarin Announces Positive Phase 3 Pivotal Study Results for VOXZOGO® (vosoritide) in Children with Hypochondroplasia

      May 21, 2026
      BioArctic Interim Report for the period January – March 2026
      Biotech

      BioArctic Interim Report for the period January – March 2026

      May 20, 2026
      FDA Grants Breakthrough Therapy Designation to VERTANICAL’s VER-01, a First-in-Class Non-Opioid Investigational Treatment for Chronic Low Back Pain
      Biotech

      FDA Grants Breakthrough Therapy Designation to VERTANICAL’s VER-01, a First-in-Class Non-Opioid Investigational Treatment for Chronic Low Back Pain

      May 19, 2026
      LOTTE Biologics Expands Antibody Manufacturing Agreement with Ottimo Pharma
      Biotech

      LOTTE Biologics Expands Antibody Manufacturing Agreement with Ottimo Pharma

      May 18, 2026
      BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update
      Biotech

      BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update

      May 17, 2026
      Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
      Biotech

      Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success

      May 16, 2026
      SN BioScience Doses First Patient in Phase 1b/2 Clinical Trial of ‘SNB-101’
      Biotech

      SN BioScience Doses First Patient in Phase 1b/2 Clinical Trial of ‘SNB-101’

      May 15, 2026
      1 2 3 … 142 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026